STOKE THERAPEUTICS INC (STOK)
US86150R1077 - Common Stock
ChartMill assigns a Buy % Consensus number of 84% to STOK. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 24.14. This target is 97.71% above the current price.
STOK was analyzed by 15 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about STOK.
In the previous month the buy percentage consensus was at a similar level.
STOK was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-11 | Needham | Reiterate | Buy -> Buy |
| 2024-04-04 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-03-26 | TD Cowen | Upgrade | Hold -> Buy |
| 2024-03-26 | Needham | Maintains | Buy -> Buy |
| 2024-03-26 | Wedbush | Maintains | Outperform -> Outperform |
| 2024-03-26 | JP Morgan | Maintains | Neutral -> Neutral |
| 2024-03-26 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-03-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-02-16 | Needham | Reiterate | Buy -> Buy |
| 2023-11-07 | Needham | Maintains | Buy -> Buy |
| 2023-08-08 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2023-08-08 | Credit Suisse | Reiterate | Outperform -> Outperform |
| 2023-08-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-07 | Needham | Reiterate | Buy |
| 2023-07-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-26 | Needham | Reiterate | Buy -> Buy |
| 2023-06-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-23 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2023-05-05 | Needham | Reiterate | Buy |
| 2023-05-05 | Credit Suisse | Reiterate | Outperform |
| 2023-05-05 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-05-01 | B of A Securities | Upgrade | Underperform -> Neutral |
| 2023-03-16 | Needham | Reiterate | Buy |
| 2023-03-07 | Cantor Fitzgerald | Reiterate | Overweight |
| 2023-03-07 | Needham | Reiterate | Buy |
| 2023-03-07 | Wedbush | Maintains | Outperform |
| 2023-03-07 | Credit Suisse | Maintains | Outperform |
| 2023-03-07 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-01-11 | Credit Suisse | Maintains | Outperform |
| 2022-12-05 | HC Wainwright & Co. | Maintains | Buy |